11-108244873-C-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2_SupportingPM3PVS1PM5_Supporting
This summary comes from the ClinGen Evidence Repository: The c.748C>T (p.Arg250*) variant in ATM is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. This alteration results in a termination codon upstream of the most C-terminus pathogenic alteration (ATM p.Arg3047*), as classified by the HBOP VCEP, and is expected to be more deleterious. This variant has been detected in numerous individuals with Ataxia-Telangiectasia (PMIDs: 10330348, 12552559, 20840352, 21778326, 22006793, 26896185, 30816533, 31611883). The highest population minor allele frequency in gnomAD v2.1.1 0.00003 (1/34560) which meets the PM2 threshold of n≤1 alleles when sub-population frequency is >0.00001 (PM2_Supporting met). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant ATM-related cancer predisposition and autosomal recessive Ataxia-Telangiectasia based on the ACMG/AMP criteria applied, as specified by the HBOP VCEP. (PVS1, PM5_Supporting, PM3_VeryStrong, PM2_Supporting) LINK:https://erepo.genome.network/evrepo/ui/classification/CA336868/MONDO:0700270/020
Frequency
Consequence
NM_000051.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- ATM-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | MANE Select | c.748C>T | p.Arg250* | stop_gained | Exon 7 of 63 | ENSP00000501606.1 | Q13315 | ||
| ATM | TSL:1 | c.748C>T | p.Arg250* | stop_gained | Exon 8 of 64 | ENSP00000388058.2 | Q13315 | ||
| ATM | TSL:1 | c.748C>T | p.Arg250* | stop_gained | Exon 7 of 30 | ENSP00000434327.3 | H0YDU7 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251002 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461624Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727120 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at